Human LILRB4/CD85k/ILT-3 quantitates human LILRB4/CD85k/ILT-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LILRB4/CD85k/ILT-3.
Accession number
Membre de la famille similaire à l’antigène CD85 K ; CD85k ; glycoprotéine 49 B ; glycoprotéine 49 b ; gp49 ; Gp49b ; GP49B2 ; HM18 ; ILT3 ; ILT-3 ; transcript similaire à l’immunoglobuline 3 ; récepteur similaire à l’Ig leucocytaire B4 ; récepteur similaire à l’immunoglobuline leucocytaire B4 ; récepteur similaire à l’immunoglobuline leucocytaire 5 ; membre B de la sous-famille de récepteurs similaire à l’immunoglobuline leucocytaire 4 ; récepteur similaire à l’immunoglobuline leucocytaire, sous-famille B (avec domaines TM et ITIM), membre 4 ; récepteur similaire à l’immunoglobuline leucocytaire, sous-famille B, membre 4 ; récepteur de surface des leucocytes ; Lilrb4 ; LIR5 ; LIR-5 ; glycoprotéine de surface des mastocytes Gp49B ; récepteur inhibiteur des monocytes HM18
Dose range
1.3 to 300 ng/ml
Sensitivity of the dosage
1.3 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human LILRB4/CD85k/ILT-3 quantitates human LILRB4/CD85k/ILT-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LILRB4/CD85k/ILT-3.
Human LILRB4/CD85k/ILT-3 quantitates human LILRB4/CD85k/ILT-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LILRB4/CD85k/ILT-3.
This gene is part of the family of leukocyte immunoglobulin receptors (LIR), which is found in a group of genes in the chromosome region 19q13.4. The coded protein belongs to the class B subfamily of LIR receptors containing two or four extracellular domains of immunoglobulin, one transmembrane domain and two to four inhibitory motifs of tyrosine-based cytoplasmic immunoreceptor (ITIM). The receptor is expressed on immune cells where it binds to MHC Class I molecules on antigen-containing cells and transduces a negative signal that inhibits stimulation of an immune reaction. The receptor can also function in the capture and presentation of antigens. It is thought that inflammatory responses and cytotoxicity should be controlled to help concentrate the immune response and limit self-reactivity. Several transcription variants coding different isoforms were found for this gene. [provided by RefSeq, July 2008].
Sensitivity
Sensitivity of the dosage: 1.3 ng/ml.
Measurement range
Dose range: 1.3 to 300 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: LILRB4 (CD85k).
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17184593
Specifications
Accession number
Member of the family similar to CD85 K antigen; CD85k; glycoprotein 49 B; glycoprotein 49 b; gp49; Gp49b; GP49B2; HM18; ILT3; ILT-3; transcript similar to immunoglobulin 3; receptor similar to leukocyte Ig B4; receptor similar to leukocyte Immunoglobulin B4; receptor similar to leukocyte Ig B4; receptor similar to leukocyte Ig